Allergists Respond To FDA Committee Recommendation On Asthma Medication, Encourage Patients With Questions To Contact Physicians

The nation's allergists urged a Joint FDA Advisory Committee today to continue to make long-acting beta-2 agonists available for the treatment of moderate-to-severe asthma in appropriate patients. More at...